MedTrace Logo

Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System

NCT04708106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2021-07-22

No results posted yet for this study

Summary

The study will assess product use behaviors, biomarkers of exposure, subjective effects, and safety in smokers who switch to a RELX ENDS over 8-weeks.

Conditions

  • Electronic Cigarette Use

Interventions

OTHER

RELX ENDS Tobacco Flavor

Ad libitum use of the RELX ENDS Tobacco Flavor product

OTHER

RELX ENDS Menthol Flavor

Ad libitum use of the RELX ENDS Menthol product

OTHER

RELX ENDS Tobacco and Menthol Flavors

Ad libitum use of the RELX ENDS Tobacco and Menthol Flavor products

Sponsors & Collaborators

  • Cheerain HK Limited

    lead INDUSTRY

Principal Investigators

  • Donald Graff, PharmD · Sponsor Representative

  • Mark Adams, MD · AMR - Lexington

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-07-01
Completion
2021-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04708106 on ClinicalTrials.gov